WBC Disorders Flashcards
(44 cards)
Basic principles of Leukopenia and Leukocytosis
Hematopoeisis occurs via a step wise maturation of CD34+ hematopoietic stem cells
Cells mature and are released from the bone marrow into the blood
A normal WBC count is approx 5-10 K/microL
- a low WBC count = leukopenia
- a high WBC count = leukocytosis
- a low or high WBC count is usually due to a decrease or increase in one particular cell lineage
Neutropenia
Neutropenia refers to a decreased number of circulating neutrophils
Causes
- drug toxicity (eg chemo with alkylating agents) –> damage to stem cells results in decreased production of WBCs, especially neutrophils
- severe infection (eg gram neg sepsis) –> increased movement of neutrophils into tissues results in decreased circulating neutrophils
- as a treatment, GM-CSF or G-CSF may be used to boost granulocyte production, thereby decreasing risk of infection in neutropenic
Lymphopenia
Decreased number of circulating lymphocytes
Causes
- Immunodeficiency (eg DiGeorge syndrome or HIV)
- high cortisol state –> induces apoptosis of lymphocytes
- autoimmune destruction (eg SLE)
- whole body radiation –> lymphocytes are highly sensitive to radiation –> lymphopenia is the earliest change to emerge after whole body radiation
Causes of neutrophilic leukocytosis
- bacterial infection or tissue necrosis –> induces release of marginated pool and bone marrow neutrophils, including immature forms (left shift); immature cells are characterized by decreased Fc receptors (CD16)
- high cortisol state –> impairs leukocyte adhesion = release of marginated pool of neutrophils
Causes of monocytosis
- chronic inflammatory states (autoimmune or infectious)
- malignancy
Causes of eosinophila
- allergic reactions (type I hypersensitivity)
- parasitic infections
- Hodgkins lymphoma
eosinophila is driven by increased eosinophil chemotactic factor
Causes of basophila
Classically seen in CML
Causes of lymphocytic leukocytosis
- viral infections –> T lymphocytes undergo hyperplasia in response to virally infected cells
- bordetella pertussis infection –> bacteria produce lymphocytosis promoting factor –> blocks circulating lymphocytes from leaving the blood to enter the lymph node
Infectious Mononucleosis
EBV infection that results in a lymphocytic leukocytosis comprised of reactive CD8 T cells
- CMV is a less common cause
EBV primarily infects:
- oropharynx –> results in pharyngitis
- liver –> results in hepatitis with hepatomegaly and elevated liver enzymes
- B cells
CD8 T cell response leads to:
- generalized lymphadenopathy due to T cell hyperplasia in the lymph node paracortex
- splenomegaly due to T-cell hyperplasia in the periarterial lymphatic sheath
- high WBC count with atypical lymphocytes (reactive CD8 T cells) in the blood
Monospot test is used for screening
- detects IgM antibodies that cross-react with horse or sheep RBCs = heterophile antibodies
- usually turns positive within 1 week after infection
- a neg monospot test suggests CMV as a possible cause of mono
- definitive diagnosis is made by serologic testing for the EBV viral capsin antigen
Complications of mono
- increased risk for splenic rupture –> patients are advised to avoid contact sports for one month
- rash if exposed to ampicillin
- dormancy of virus in B cells leads to increased risk for both recurrence and b-cell lymphoma, especially if immunodeficiency develops
Basic principles of acute leukemia
Neoplastic proliferation of blasts –> defined as the accumulation of >20% blasts in the bone marrow
- increased blasts crowd out normal hematopoiesis, resulting in an “acute” presentation with anemia (fatigue), thrombocytopenia (bleeding), or neutropenia “infection”
Blasts usually enter the blood stream –> results in a high WBC
- blasts are large, immature cells, often with punched out nucleoli
Acute lymphoblastic leukemia (ALL)
Neoplastic accumulation of lymphoblasts (>20%) in the bone marrow
- lymphoblasts are characterized by positive nuclear staining for TdT = a DNA polymerase
- TdT is absent in myeloid blasts and mature lymphocytes
Most commonly arises in children –> associated with Down syndrome (usually after the age of 5)
Subclassified into B-ALL and T-ALL based on surface markers
B-ALL
Most common type of ALL
- usually characterized by lymphoblasts (TdT+) that express CD10, CD19 and CD20
- excellent response to chemo –> requires prophylaxis to scrotum and CSF
Prognosis is based on cytogenetic abnormalities
- t(12;21) –> good prognosis, more commonly seen in children
- t(9;22) –> poor prognosis, more commonly seen in adults (Ph+)
T-ALL
Characterized by lymphoblasts (TdT+) that express markers ranging from CD2-CD8
- blasts do not express CD10
Usually presents in teenagers as a mediastinal (thymic) mass –> called acute lymphoblastic lymphoma because the malignant cells for a mass
Acute myeloid leukemia
Neoplastic accumulation of immature myeloid cells (>20%) in the bone marrow
- myeloblasts are usually characterized by positive cytoplasmic staining for myeloperoxidase
- crystal aggregates of MPO may be seen as Auer rods
Most commonly arises in older adults (50-60 yrs)
Subclassified based on cytogenetic abnormalities, lineage of myeloblasts, and surface markers
Subtypes of AML
- Acute promyelocytic leukemia = characterized by t(15;17) –> involves translocation of the RAR on chromosome 17 to chromosome 15
- RAR disruption blocks maturation and promyelocytes accumulate
- abnormal promyelocytes contain numerous primary granules that increase the risk for DIC
- treatment is with all-trans-retinoic acid (ATRA) –> binds the altered receptor and causes the blasts to mature - Acute monocytic leukemia = proliferation of monoblasts, usually lack MPO
- blasts characteristically infiltrate gums - Acute megakaryoblastic leukemia = proliferation of megakaryoblasts –> lack MPO
- associated with Down syndrome (usually before the age of 5)
Myelodysplastic syndromes
May give rise to AML, especially with prior exposure to alkylating agents or radiotherapy
- myelodysplastic syndromes usually present with cytopenias, hypercellular bone marrow, abnormal maturation of cells, and increased blasts (<20%)
- most patients die from infection or bleeding, though some progress to acute leukemia
Basic principles of chronic leukemia
Neoplastic proliferation of mature circulating lymphocytes –> characterized by a high WBC count
- usually insidious in onset and seen in older adults
Chronic lymphocytic leukemia
Neoplastic proliferation of naive B cells that co-express CD5 and CD20
- most common leukemia overall
- increased lymphocytes and smudge cells are seen on blood smear
- involvement of lymph nodes leads to generalized lymphadenopathy –> called small lymphocytic lymphoma
Complications
- hypogammaglobulinemia –> infection is the most common cause of death
- autoimmune hemolytic anemia
- transformation to diffuse large B cell lymphoma –> marked clinically by an enlarging lymph node of spleen
Hairy cell leukemia
Neoplastic proliferation of mature B cells characterized by hairy cytoplasmic processes
- cells are positive for tartrate resistant acid phosphatase (TRAP)
- clinical features include splenomegaly (due to accumulation of hairy cells in the red pulp) and “dry tap” on bone marrow aspiration (due to marrow fibrosis)
- lymphadenopathy is usually absent
Excellent response to cladribine = adenosine deaminase inhibitor –> adenosine accumulates to toxic levels in neoplastic B cells
Adult T cell leukemia/lymphoma
Neoplastic proliferation of mature CD4 T cells
- associated with HTLV-1
- most commonly seen in Japan and the caribbean
Clinical features
- rash (skin infiltration)
- generalized lymphadenopathy with hepatosplenomegaly
- lytic bone lesions with hypercalcemia
Mycosis fungoides
Neoplastic proliferation of mature CD4+ T cells that infiltrate the skin, producing localized skin rash, plaques, and nodules
- aggregates of neoplastic cells in the epidermis = pautrier microabscesses
Cells can spread to involve the blood –> called Sezary syndrome
- characteristic lymphocytes with cerebriform nuclei are seen on blood smears
Basic principles of myeloproliferative disorders
Neoplastic proliferation of mature cells of myeloid lineage
- disease of late adulthood (avg age 50-60 years)
- results in high WBC count with hypercellular bone marrow
- cells of all myeloid lineages are increased –> classified based on the dominant myeloid cell produced
Complications
- increased risk for hyperuricemia and gout due to high turnover of cells
- progression to marrow fibrosis or transformation to acute leukemia
Chronic myeloid leukemia
Neoplastic proliferation of mature myeloid cells, especially granulocytes and their precursors
- basophils are characteristically increased
Driven by t(9;22) = philadelphia chromosome –> generates a BCR-ABL fusion protein with increased TK activity
- first line treatment is imatinib –> blocks TK activity
Splenomegaly is common –> enlarging spleen suggests progression to accelerated phase of disease –> transformation to acute leukemia usually follows shortly thereafter
- can transform to AML (2/3) of cases or ALL (1/3 of cases) since mutation is in a pluripotent stem cells